Tirzepatide × RIPTIX — lab test, April 2026
COA 4I2-TPB matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
4I2-TPBTest results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 30 mg · Lab measured 36.07 mg
120% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 9 mg using the measured mass, against 7.5 mg on the label — 20% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 4I2-TPB |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide from RIPTIX, performed by Uzorak on April 21, 2026. Reported purity: 99.74%. Net content: 36.07 mg against 30 mg labeled (120% of label). Tested content exceeds the labeled amount by 20%. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion